Bioregenx (BRGX) Total Debt (2021 - 2026)

Bioregenx's Total Debt history runs 6 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• On a quarterly basis, Total Debt rose 83.46% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 83.46% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, down 42.06% from the prior year.
• Total Debt grew to $2.1 million in Q1 2026 per BRGX's latest filing, from $1.2 million in the prior quarter.
• Across five years, Total Debt topped out at $2.1 million in Q1 2026 and bottomed at $200000.0 in Q2 2023.
• The 5-year median for Total Debt is $1.1 million (2025), against an average of $1.1 million.
• Across the five-year window, Total Debt jumped 916.6% in 2024 and slumped 42.06% in 2025, its largest moves.
• Year by year, Total Debt stood at $204189.0 in 2022, then jumped by 341.44% to $901362.0 in 2023, then jumped by 124.33% to $2.0 million in 2024, then slumped by 42.06% to $1.2 million in 2025, then jumped by 78.21% to $2.1 million in 2026.
• Per Business Quant, the three latest BRGX Total Debt figures stand at $2.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025).